08:00 , Nov 18, 2013 |  BC Week In Review  |  Company News

Anteis, Merz deal

Merz will acquire dermatology company Anteis. Merz markets Anteis' Belotero injectable devices in the U.S., Germany, Switzerland, Austria, Italy, Russia and the U.K. under a 2004 deal, including Belotero Balance, which is approved in the...
07:00 , Sep 21, 2009 |  BC Week In Review  |  Clinical News

Belotero Balance regulatory update

Merz said FDA accepted for filing a PMA for Belotero Balance to treat moderate to severe wrinkles and folds. The hyaluronic acid based monophasic gel dermal filler that utilizes a cohesive polydensified matrix technology is...